Log in to save to my catalogue

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches...

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8403122

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches

About this item

Full title

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches

Publisher

New York: Springer US

Journal title

Metabolomics, 2021-09, Vol.17 (9), p.78-78, Article 78

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Background
Alzheimer's disease (AD) is one of the most common causes of dementia in old people. Neuronal deficits such as loss of memory, language and problem-solving are severely compromised in affected patients. The molecular features of AD are Aβ deposits in plaques or in oligomeric structures and neurofibrillary tau tangles in brain. However...

Alternative Titles

Full title

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8403122

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8403122

Other Identifiers

ISSN

1573-3882

E-ISSN

1573-3890

DOI

10.1007/s11306-021-01828-w

How to access this item